Page last updated at 08:25 GMT, Friday, 4 January 2013
Prof Yang: 'Lucentis should help 12,000 diabetics'
Patients whose eyesight is badly affected by diabetes are going to be allowed to use the drug Lucentis throughout the UK.
The National Institute for Health and Clinical Excellence (NICE) said "no" last year to Lucentis on cost grounds. However in Scotland, the Scottish Medicines Consortium approved it last month and NICE has followed suit.
Professor Yit Yang, an ophthalmologist at the Royal Wolverhampton Hospital said: "It's very important news for the thousands of patients with diabetes."
He continued: "The drug Lucentis has the ability to reduce swelling at the back of the eye quite quickly, and vision functions better... 12,000 people in the UK should benefit from this treatment."
This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.